NO144743C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye penicillinderivater - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye penicillinderivater

Info

Publication number
NO144743C
NO144743C NO4776/73A NO477673A NO144743C NO 144743 C NO144743 C NO 144743C NO 4776/73 A NO4776/73 A NO 4776/73A NO 477673 A NO477673 A NO 477673A NO 144743 C NO144743 C NO 144743C
Authority
NO
Norway
Prior art keywords
preparation
therapeutically active
penicillin derivatives
analogy procedure
new penicillin
Prior art date
Application number
NO4776/73A
Other languages
English (en)
Other versions
NO144743B (no
Inventor
Hisao Tobiki
Hirotada Yamada
Iwao Nakatsuka
Takenari Nakagome
Kozo Shimago
Toshiaki Komatsu
Hiroshi Noguchi
Shigeru Okano
Akio Izawa
Yasuko Eda
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Publication of NO144743B publication Critical patent/NO144743B/no
Publication of NO144743C publication Critical patent/NO144743C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO4776/73A 1972-12-15 1973-12-14 Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye penicillinderivater NO144743C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP12663472A JPS5417754B2 (no) 1972-12-15 1972-12-15

Publications (2)

Publication Number Publication Date
NO144743B NO144743B (no) 1981-07-20
NO144743C true NO144743C (no) 1981-10-28

Family

ID=14940035

Family Applications (1)

Application Number Title Priority Date Filing Date
NO4776/73A NO144743C (no) 1972-12-15 1973-12-14 Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye penicillinderivater

Country Status (17)

Country Link
US (1) US3954733A (no)
JP (1) JPS5417754B2 (no)
AR (1) AR199711A1 (no)
AU (1) AU470628B2 (no)
BE (1) BE808681A (no)
CA (1) CA1032158A (no)
CH (1) CH596217A5 (no)
DD (1) DD109876A5 (no)
DE (1) DE2362279C2 (no)
DK (1) DK138602B (no)
FR (1) FR2210385B1 (no)
GB (1) GB1446484A (no)
HU (1) HU167854B (no)
NL (1) NL7317287A (no)
NO (1) NO144743C (no)
SE (1) SE411349B (no)
ZA (1) ZA739278B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5751837B2 (no) * 1973-04-05 1982-11-04
CA1074784A (en) * 1974-09-06 1980-04-01 Sumitomo Chemical Company N-ACYLAMINO-.alpha.-ARYLACETAMIDO CEPHALOSPORINS
FR2288521A1 (fr) * 1974-10-25 1976-05-21 Merck Patent Gmbh Nouvelles penicillines et procede pour leur preparation
JPS5195090A (en) * 1975-02-14 1976-08-20 66 * dd22 * 33 hidorokishipiridajin 44 karubokishiamido * 22 * paraahidorokishifueniru * asetoamido * penishiransanno seiho
GB1568962A (en) * 1975-10-31 1980-06-11 Beecham Group Ltd Reparation and compositions containing them (heterocyclic-carbonylamino)pencillins methods for their p
US4026881A (en) * 1976-04-16 1977-05-31 Pfizer Inc. 6-(D-2-[4-hydroxy-1,5-naphthyridine-3-carboxamido]-2-[4-hydroxyphenyl]acetamido)-2,2-dimethyl-3-(5-tetrazolyl)penam
JPS5346997A (en) * 1976-10-06 1978-04-27 Bristol Myers Co Antiibacterial agent
DE2833018A1 (de) * 1977-08-12 1979-03-01 Taisho Pharma Co Ltd Neue penicillinderivate und diese enthaltende mittel
NO155346C (no) * 1978-05-31 1987-03-18 Sumitomo Chemical Co Frgm. for rensning av raatt natrium-6-(d(-)-alfa-(4-hydroksy-1,5-naftyridin-3-karboksamido)-fenylacetamido)-penicillanat eller natrium-6-(d(-)-alfa-(4-hydroksy-1,5-naftyridin-3-karboksamido)-p-hydrosyfenylacetamido)-penicillanat
US4231928A (en) * 1979-04-24 1980-11-04 Bristol-Myers Company Antibacterial agents
IT1215277B (it) * 1985-05-27 1990-01-31 Pomezia Roma A Derivato chinolin-lattaminico ad attivita' antibatterica ed inibitrice delle b-lattamasi.
KR20030078958A (ko) * 2001-03-01 2003-10-08 시오노기세이야쿠가부시키가이샤 Hiv 인테그라제 저해 활성을 갖는 질소 함유의헤테로아릴 화합물
ES2446416T3 (es) 2005-12-09 2014-03-07 Amgen, Inc. Compuestos basados en quinolona que presentan actividad inhibidora de prolil hidroxilasa, composiciones y usos de los mismos
CA2672656C (en) * 2006-12-18 2012-03-20 Amgen Inc. Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
US8048892B2 (en) * 2006-12-18 2011-11-01 Amgen Inc. Azaquinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
CA2683956C (en) * 2007-04-18 2012-12-18 Amgen Inc. Quinolones and azaquinolones that inhibit prolyl hydroxylase
US7569726B2 (en) * 2007-04-18 2009-08-04 Amgen Inc. Indanone derivatives that inhibit prolyl hydroxylase
CA2685219C (en) * 2007-05-04 2012-06-19 Amgen Inc. Diazaquinolones that inhibit prolyl hydroxylase activity
CA2685216C (en) * 2007-05-04 2014-07-08 Amgen Inc. Thienopyridine and thiazolopyridine derivatives that inhibit prolyl hydroxylase activity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3248387A (en) * 1963-02-07 1966-04-26 American Home Prod Amino-acylamino-penicillanic acids
BE667629A (no) * 1964-07-29
GB1130445A (en) * 1966-04-26 1968-10-16 Beecham Group Ltd Penicillins
DE2104580C3 (de) * 1971-02-01 1981-04-02 Bayer Ag, 5090 Leverkusen Acylureidopenicilline
FR2165744A1 (en) * 1971-12-28 1973-08-10 Sumitomo Chemical Co 6-(alpha-aminophenylacetamido)-and 6-(alpha-aminothienylacetamido) - -penicillanic acid derivs antibiotics

Also Published As

Publication number Publication date
HU167854B (no) 1975-12-25
AU6334173A (en) 1975-06-12
BE808681A (fr) 1974-06-14
SE411349B (sv) 1979-12-17
DD109876A5 (no) 1974-11-20
JPS5417754B2 (no) 1979-07-02
JPS4982683A (no) 1974-08-08
DK138602C (no) 1979-03-05
AR199711A1 (es) 1974-09-23
NL7317287A (no) 1974-06-18
DK138602B (da) 1978-10-02
CA1032158A (en) 1978-05-30
DE2362279A1 (de) 1974-06-20
AU470628B2 (en) 1976-03-25
DE2362279C2 (de) 1982-04-01
FR2210385B1 (no) 1976-09-03
ZA739278B (en) 1974-10-30
US3954733A (en) 1976-05-04
CH596217A5 (no) 1978-03-15
GB1446484A (en) 1976-08-18
NO144743B (no) 1981-07-20
FR2210385A1 (no) 1974-07-12

Similar Documents

Publication Publication Date Title
NO145576C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive penicillinderivater
NO144885C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzodiazepinderivater
NO141407C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive etylenderivater
NO144743C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye penicillinderivater
NO143909C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive penicillinforbindelser
NO148848C (no) Analogifremgangsmaate ved fremstilling av nye antibiotisk aktive spiroimidazolidin-rifamyciner
NO141687C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-oxo-2,2-disubstituerte-5-indanyloxy-eddiksyrer
NO149281C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 7alfa-metoksycephalosporinderivater
NO143575C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive prostansyre-derivater
NO142865C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive karbazoler
NO142033C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive isopropylamino-3-fenoksypropanoler
NO137782C (no) Analogifremgangsmaate for fremstilling av nye farmakologisk aktive amino-fenyl-etanolaminer
NO141648C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive 2-oxazolinderivater
NO138599C (no) Analogifremgangsmaate til fremstilling av nye, terapeutisk virksomme tienopyrimidinderivater
SE416811B (sv) Analogiforfarande for framstellning av nya, antibakteriellt aktiva derivat av amidinopenicillansyra
NO141850C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrazolderivater.
NO741125A (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive pyrido-pyrimidin-derivater.
NO741744L (no) Analogifremgangsmåte for fremstilling av nye terapeutisk aktive derivater av naftyridin.
NO142260C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tienotriazolodiazepinderivater
NO146497C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 2-anilino-oxazoliner
NO142077C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-cyclohexyl-3-pyrrolidinyl)-benzamider
SE389120B (sv) Forfarande for framstellning av nya, sasom harkosmetiskt aktiva substanser anvendbara oligopeptidderivat
NO740411L (no) Analogifremgangsmåte for fremstilling av nye terapeutisk aktive derivater av isoindolin-1-on.
NO138660C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 3-(piperazinalkyl)-2,4-kinazolindioner
NO144039C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk virksomme benzofuranderivater